Denise C Hsu1, Kimberly F Breglio1, Luxin Pei1, Chun-Shu Wong1, Bruno B Andrade2,3,4,5,6, Virginia Sheikh1, Margery Smelkinson7, Constantinos Petrovas8, Adam Rupert9, Leonardo Gil-Santana2,3,4, Adrian Zelazny10, Steven M Holland11, Kenneth Olivier12, Daniel Barber13, Irini Sereti1. 1. Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland. 2. Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil. 3. Multinational Organization Network Sponsoring Translational and Epidemiological Research Initiative, Fundação José Silveira, Salvador, Bahia, Brazil. 4. Curso de Medicina, Faculdade de Tecnologia e Ciências, Salvador, Bahia, Brazil. 5. Wellcome Centre for Infectious Disease Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa. 6. Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee. 7. Biological Imaging Section, NIAID, Bethesda, Maryland. 8. Tissue Analysis Core Section, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland. 9. Functional Immunology Section, AIDS Monitoring Laboratory, SAIC-Frederick, National Cancer Institute, National Institutes of Health, Frederick, Maryland. 10. Department of Laboratory Medicine, NIAID, NIH, Bethesda, Maryland. 11. Laboratory of Clinical Infectious Diseases, NIAID Bethesda, Maryland. 12. Pulmonary Clinical Medicine Section, National Heart, Lung, and Blood Institute. 13. Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, Maryland.
Abstract
Background: Immune reconstitution inflammatory syndrome (IRIS) is an aberrant inflammatory response in individuals with advanced human immunodeficiency virus (HIV) infection, after antiretroviral therapy (ART) initiation. The pathogenesis of Mycobacterium avium complex (MAC)-associated IRIS has not been fully elucidated. Methods: We investigated monocyte and CD4+ T-cell responses in vitro, tumor necrosis factor (TNF) expression in tissues, and plasma cytokines and inflammatory markers, in 13 HIV-infected patients with MAC-IRIS and 14 HIV-uninfected patients with pulmonary MAC infection. Results: Prior to ART, HIV-infected compared with HIV-uninfected patients, had reduced TNF+ monocytes (P = .013), although similar cytokine (interferon gamma [IFN-γ], TNF, interleukin 2 [IL-2], and interleukin 17 [IL-17])-expressing CD4+ T cells. During IRIS, monocyte cytokine production was restored. IFN-γ+ (P = .027), TNF+ (P = .004), and polyfunctional CD4+ T cells (P = 0.03) also increased. These effectors were T-betlow, and some expressed markers of degranulation and cytotoxic potential. Blockade of cytotoxic T-lymphocyte associated protein 4 and lymphocyte activation gene-3 further increased CD4+ T-cell cytokine production. Tissue immunofluorescence showed higher proportions of CD4+ and CD68+ (monocyte/macrophage) cells expressed TNF during IRIS compared with HIV-uninfected patients. Plasma IFN-γ (P = .048), C-reactive protein (P = .008), and myeloperoxidase (P < .001) levels also increased, whereas interleukin 10 decreased (P = .008) during IRIS. Conclusions: Advanced HIV infection was associated with impaired MAC responses. Restoration of monocyte responses and expansion of polyfunctional MAC-specific T-betlow CD4+ T cells with cytotoxic potential after ART initiation may overwhelm existing regulatory and inhibitory mechanisms, leading to MAC-IRIS.
Background: Immune reconstitution inflammatory syndrome (IRIS) is an aberrant inflammatory response in individuals with advanced human immunodeficiency virus (HIV) infection, after antiretroviral therapy (ART) initiation. The pathogenesis of Mycobacterium avium complex (MAC)-associated IRIS has not been fully elucidated. Methods: We investigated monocyte and CD4+ T-cell responses in vitro, tumor necrosis factor (TNF) expression in tissues, and plasma cytokines and inflammatory markers, in 13 HIV-infectedpatients with MAC-IRIS and 14 HIV-uninfectedpatients with pulmonary MAC infection. Results: Prior to ART, HIV-infected compared with HIV-uninfectedpatients, had reduced TNF+ monocytes (P = .013), although similar cytokine (interferon gamma [IFN-γ], TNF, interleukin 2 [IL-2], and interleukin 17 [IL-17])-expressing CD4+ T cells. During IRIS, monocyte cytokine production was restored. IFN-γ+ (P = .027), TNF+ (P = .004), and polyfunctional CD4+ T cells (P = 0.03) also increased. These effectors were T-betlow, and some expressed markers of degranulation and cytotoxic potential. Blockade of cytotoxic T-lymphocyte associated protein 4 and lymphocyte activation gene-3 further increased CD4+ T-cell cytokine production. Tissue immunofluorescence showed higher proportions of CD4+ and CD68+ (monocyte/macrophage) cells expressed TNF during IRIS compared with HIV-uninfectedpatients. Plasma IFN-γ (P = .048), C-reactive protein (P = .008), and myeloperoxidase (P < .001) levels also increased, whereas interleukin 10 decreased (P = .008) during IRIS. Conclusions: Advanced HIV infection was associated with impaired MAC responses. Restoration of monocyte responses and expansion of polyfunctional MAC-specific T-betlowCD4+ T cells with cytotoxic potential after ART initiation may overwhelm existing regulatory and inhibitory mechanisms, leading to MAC-IRIS.
Authors: Harry Z Qui; Adam T Hagymasi; Suman Bandyopadhyay; Marie-Clare St Rose; Raghunath Ramanarasimhaiah; Antoine Ménoret; Robert S Mittler; Scott M Gordon; Steven L Reiner; Anthony T Vella; Adam J Adler Journal: J Immunol Date: 2011-08-31 Impact factor: 5.422
Authors: Daniel L Barber; Katrin D Mayer-Barber; Lis R V Antonelli; Mark S Wilson; Sandra White; Patricia Caspar; Sara Hieny; Irini Sereti; Alan Sher Journal: Blood Date: 2010-07-23 Impact factor: 22.113
Authors: Anne Bourgarit; Guislaine Carcelain; Valerie Martinez; Caroline Lascoux; Veronique Delcey; Brigitte Gicquel; Eric Vicaut; Philippe H Lagrange; Daniel Sereni; Brigitte Autran Journal: AIDS Date: 2006-01-09 Impact factor: 4.177
Authors: Graeme Meintjes; Katalin Andrea Wilkinson; Molebogeng Xheeda Rangaka; Keira Skolimowska; Kerryn van Veen; Musaed Abrahams; Ronnett Seldon; Dominique J Pepper; Kevin Rebe; Priscilla Mouton; Gilles van Cutsem; Mark Patrick Nicol; Gary Maartens; Robert John Wilkinson Journal: Am J Respir Crit Care Med Date: 2008-08-28 Impact factor: 21.405
Authors: Caian L Vinhaes; Deivide Oliveira-de-Souza; Paulo S Silveira-Mattos; Betania Nogueira; Ruiru Shi; Wang Wei; Xing Yuan; Guolong Zhang; Ying Cai; Clifton E Barry; Laura E Via; Kiyoshi F Fukutani; Bruno B Andrade; Katrin D Mayer-Barber Journal: Cytokine Date: 2019-06-18 Impact factor: 3.861
Authors: Maura Manion; Dimana Dimitrova; Luxin Pei; Juan Gea-Banacloche; Adrian Zelazny; Andrea Lisco; Christa Zerbe; Alexandra F Freeman; Steven M Holland; Christopher G Kanakry; Jennifer A Kanakry; Irini Sereti Journal: Clin Infect Dis Date: 2020-02-03 Impact factor: 9.079
Authors: Maura Manion; Augusto Dulanto Chiang; Luxin Pei; Chun-Shu Wong; Pavel Khil; Dima A Hammoud; Megan Anderson; Elizabeth Laidlaw; Safia Kuriakose; Andrea Lisco; Adrian M Zelazny; John P Dekker; Irini Sereti Journal: J Infect Dis Date: 2021-08-02 Impact factor: 5.226
Authors: Deivide Oliveira-de-Souza; Caian L Vinhaes; María B Arriaga; Nathella Pavan Kumar; Artur T L Queiroz; Kiyoshi F Fukutani; Subash Babu; Bruno B Andrade Journal: Sci Rep Date: 2020-07-09 Impact factor: 4.379
Authors: Caroline C Guarda; Paulo S M Silveira-Mattos; Sètondji C M A Yahouédéhou; Rayra P Santiago; Milena M Aleluia; Camylla V B Figueiredo; Luciana M Fiuza; Suellen P Carvalho; Rodrigo M Oliveira; Valma M L Nascimento; Nívea F Luz; Valéria M Borges; Bruno B Andrade; Marilda S Gonçalves Journal: Sci Rep Date: 2019-10-15 Impact factor: 4.379
Authors: Caian L Vinhaes; Mariana Araujo-Pereira; Rafael Tibúrcio; Juan M Cubillos-Angulo; Fernanda O Demitto; Kevan M Akrami; Bruno B Andrade Journal: Life (Basel) Date: 2021-01-18
Authors: Ingeborg E A Wijting; Ferdinand W N M Wit; Casper Rokx; Eliane M S Leyten; Selwyn H Lowe; Kees Brinkman; Wouter F W Bierman; Marjo E E van Kasteren; Anneloes M Postma; Vera C M Bloemen; Ghariba Bouchtoubi; Andy I M Hoepelman; Marchina E van der Ende; Peter Reiss; Bart J A Rijnders Journal: EClinicalMedicine Date: 2019-12-13
Authors: Luxin Pei; Kiyoshi F Fukutani; Rafael Tibúrcio; Adam Rupert; Eric W Dahlstrom; Frances Galindo; Elizabeth Laidlaw; Andrea Lisco; Maura Manion; Bruno B Andrade; Irini Sereti Journal: Front Immunol Date: 2021-06-15 Impact factor: 7.561